Theodore Ashburn
Plus aucun poste en cours
Fortune : 12 518 $ au 31/12/2023
Profil
Theodore T.
Ashburn is the founder of BrainCells, Inc., Dynogen Pharmaceuticals, Inc. He worked as the Chairman of Oncorus, Inc. and held senior positions at Dicerna Pharmaceuticals, Inc., Moderna, Inc., Sanofi Oncology, and Leukine.
Ashburn received his undergraduate degree from Ball State University and doctorates from Massachusetts Institute of Technology and Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCORUS, INC.
0,38% | 31/03/2023 | 99 352 ( 0,38% ) | 12 518 $ | 31/12/2023 |
Anciens postes connus de Theodore Ashburn
| Sociétés | Poste | Fin |
|---|---|---|
| ONCORUS, INC. | Chief Executive Officer | 06/06/2023 |
| MODERNA, INC. | Corporate Officer/Principal | 01/07/2018 |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Founder | 13/11/2009 |
Sanofi Oncology
 Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Corporate Officer/Principal | - |
| Leukine | Corporate Officer/Principal | - |
Formation de Theodore Ashburn
| Ball State University (Indiana) | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ONCORUS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Commercial Services |
| Leukine |
